PortfoliosLab logoPortfoliosLab logo
CURE vs. NAIL
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

CURE vs. NAIL - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Direxion Daily Healthcare Bull 3x Shares (CURE) and Direxion Daily Homebuilders & Supplies Bull 3X Shares (NAIL). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, CURE achieves a -18.38% return, which is significantly higher than NAIL's -23.44% return. Over the past 10 years, CURE has outperformed NAIL with an annualized return of 11.65%, while NAIL has yielded a comparatively lower 3.96% annualized return.


CURE

1D
2.17%
1M
4.39%
YTD
-18.38%
6M
-18.70%
1Y
21.60%
3Y*
-0.15%
5Y*
0.21%
10Y*
11.65%

NAIL

1D
-2.39%
1M
1.50%
YTD
-23.44%
6M
-42.68%
1Y
-20.27%
3Y*
-11.78%
5Y*
-14.07%
10Y*
3.96%
*Multi-year figures are annualized to reflect compound growth (CAGR)

CURE vs. NAIL - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
CURE
Direxion Daily Healthcare Bull 3x Shares
-18.38%22.55%-8.47%-9.40%-20.51%88.30%5.02%55.66%2.82%69.32%
NAIL
Direxion Daily Homebuilders & Supplies Bull 3X Shares
-23.44%-40.43%-22.83%259.61%-75.23%168.20%-32.08%184.63%-73.96%268.71%

Correlation

The correlation between CURE and NAIL is 0.40, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.40

Correlation (3Y)
Calculated over the trailing 3-year period

0.45

Correlation (5Y)
Calculated over the trailing 5-year period

0.47

Correlation (10Y)
Calculated over the trailing 10-year period

0.43

Correlation (All Time)
Calculated using the full available price history since Aug 20, 2015

0.42

CURE vs. NAIL - Sectors Allocation Comparison


Sectors
CURE
NAIL

Healthcare

100.0%

-

Basic Materials

-

8.6%

Communication Services

-

-

Consumer Cyclical

-

71.8%

Consumer Defensive

-

-

Energy

-

-

Financial Services

-

-

Industrials

-

19.1%

Real Estate

-

0.5%

Technology

-

-

Utilities

-

-

Healthcare

CURE
100.0%
NAIL

-

Basic Materials

CURE

-

NAIL
8.6%

Communication Services

CURE

-

NAIL

-

Consumer Cyclical

CURE

-

NAIL
71.8%

Consumer Defensive

CURE

-

NAIL

-

Energy

CURE

-

NAIL

-

Financial Services

CURE

-

NAIL

-

Industrials

CURE

-

NAIL
19.1%

Real Estate

CURE

-

NAIL
0.5%

Technology

CURE

-

NAIL

-

Utilities

CURE

-

NAIL

-

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

CURE vs. NAIL — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CURE
CURE Risk / Return Rank: 1818
Overall Rank
CURE Sharpe Ratio Rank: 1616
Sharpe Ratio Rank
CURE Sortino Ratio Rank: 1919
Sortino Ratio Rank
CURE Omega Ratio Rank: 1818
Omega Ratio Rank
CURE Calmar Ratio Rank: 1717
Calmar Ratio Rank
CURE Martin Ratio Rank: 1717
Martin Ratio Rank

NAIL
NAIL Risk / Return Rank: 77
Overall Rank
NAIL Sharpe Ratio Rank: 66
Sharpe Ratio Rank
NAIL Sortino Ratio Rank: 99
Sortino Ratio Rank
NAIL Omega Ratio Rank: 99
Omega Ratio Rank
NAIL Calmar Ratio Rank: 66
Calmar Ratio Rank
NAIL Martin Ratio Rank: 66
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CURE vs. NAIL - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Direxion Daily Healthcare Bull 3x Shares (CURE) and Direxion Daily Homebuilders & Supplies Bull 3X Shares (NAIL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


CURENAILDifference
Sharpe ratioReturn per unit of total volatility

+0.73

Sortino ratioReturn per unit of downside risk

+0.77

Omega ratioGain probability vs. loss probability

1.12

1.03

+0.09

Calmar ratioReturn relative to maximum drawdown

0.70

-0.30

+1.00

Martin ratioReturn relative to average drawdown

1.61

-0.53

+2.14

CURE vs. NAIL - Sharpe Ratio Comparison

The current CURE Sharpe Ratio is 0.50, which is higher than the NAIL Sharpe Ratio of -0.23. The chart below compares the historical Sharpe Ratios of CURE and NAIL, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


CURENAILDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.50

-0.23

+0.73

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.00

-0.16

+0.17

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.24

0.04

+0.19

Sharpe Ratio (All Time)

Calculated using the full available price history

0.46

-0.00

+0.46

Drawdowns

CURE vs. NAIL - Drawdown Comparison

The maximum CURE drawdown since its inception was -69.19%, smaller than the maximum NAIL drawdown of -93.75%. Use the drawdown chart below to compare losses from any high point for CURE and NAIL.


Loading charts...

Drawdown Indicators


CURENAILDifference

Max Drawdown

Largest peak-to-trough decline

-69.19%

-93.75%

+24.56%

Max Drawdown (1Y)

Largest decline over 1 year

-31.10%

-67.85%

+36.75%

Max Drawdown (3Y)

Largest decline over 3 years

-51.93%

-82.09%

+30.16%

Max Drawdown (5Y)

Largest decline over 5 years

-52.23%

-84.40%

+32.17%

Max Drawdown (10Y)

Largest decline over 10 years

-69.19%

-93.75%

+24.56%

Current Drawdown

Current decline from peak

-35.21%

-78.12%

+42.91%

Average Drawdown

Average peak-to-trough decline

-18.15%

-43.80%

+25.65%

Ulcer Index

Depth and duration of drawdowns from previous peaks

13.43%

38.18%

-24.75%

Volatility

CURE vs. NAIL - Volatility Comparison

The current volatility for Direxion Daily Healthcare Bull 3x Shares (CURE) is 11.99%, while Direxion Daily Homebuilders & Supplies Bull 3X Shares (NAIL) has a volatility of 24.23%. This indicates that CURE experiences smaller price fluctuations and is considered to be less risky than NAIL based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


CURENAILDifference

Volatility (1M)

Calculated over the trailing 1-month period

11.99%

24.23%

-12.24%

Volatility (6M)

Calculated over the trailing 6-month period

29.83%

60.86%

-31.03%

Volatility (1Y)

Calculated over the trailing 1-year period

43.19%

87.63%

-44.44%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

43.69%

86.99%

-43.30%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

49.51%

89.20%

-39.69%

CURE vs. NAIL - Expense Ratio Comparison

CURE has a 1.08% expense ratio, which is higher than NAIL's 0.99% expense ratio.


Dividends

CURE vs. NAIL - Dividend Comparison

CURE's dividend yield for the trailing twelve months is around 1.31%, more than NAIL's 1.04% yield.


PositionTTM202520242023202220212020201920182017
CURE
Direxion Daily Healthcare Bull 3x Shares
1.31%1.12%1.17%2.02%0.38%0.02%0.17%0.40%0.70%0.18%
NAIL
Direxion Daily Homebuilders & Supplies Bull 3X Shares
1.04%1.55%0.63%0.22%0.00%0.00%0.01%0.17%0.35%1.25%

Frequently Asked Questions


CURE and NAIL have a correlation of 0.40, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

NAIL has higher volatility (24.23%) compared to CURE (11.99%). In terms of maximum drawdown, CURE dropped -69.19% vs NAIL's -93.75%.

On 10-year performance, CURE leads with 11.65% vs 3.96% for NAIL. On fees, NAIL is cheaper at 0.99% per year. On volatility, CURE has been the lower-risk option at 11.99%. The better choice depends on whether you care most about return, fees, risk, or income.

Over the 10-year period, CURE has performed better with a 11.65% return vs 3.96%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

NAIL is cheaper with a 0.99% expense ratio, compared with 1.08% for CURE.

CURE has the higher dividend yield at 1.31%, compared with 1.04% for NAIL.

CURE tracks Health Care Select Sector Index (300%), while NAIL tracks Dow Jones U.S. Select Home Construction Index (300%). Their fees differ too: 1.08% for CURE and 0.99% for NAIL.

CURE currently has the higher Sharpe Ratio (0.50 vs -0.23), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for CURE and NAIL

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer